Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Food sold in shrink wrap, on cardboard trays or in paper containers might contain any of nearly 200 chemicals linked to breast cancer, a new study warns.Commonly used food packaging materials contain 189 chemicals that.
Science Daily: Pharmacology News
SEPTEMBER 24, 2024
A mysterious type of iron-rich magma entombed within extinct volcanoes is likely abundant with rare earth elements and could offer a new way to source these in-demand metals, according to new research. Rare earth elements are found in smartphones, flat screen TVs, magnets, and even trains and missiles. They are also vital to the development of electric vehicles and renewable energy technologies such as wind turbines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioPharma Drive: Drug Pricing
SEPTEMBER 24, 2024
CEO Lars Fruergaard Jørgensen told lawmakers the company would consider new talks with insurers about the list prices of Wegovy and Ozempic if they pledge to keep the medicines on their formularies.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- The Federal Assault Weapons Ban (FAWB) would have prevented as many as 38 mass shootings that have taken place since the law lapsed in 2005, a new study estimates.Enacted by Congress in 1994, the ban prohibited the sale.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Science Daily: Pharmacology News
SEPTEMBER 24, 2024
The skeletal remains of a senior officer of Sir John Franklin's 1845 Northwest Passage expedition have been identified using DNA and genealogical analyses.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Latino and Black family doctors are more likely to hang their shingle in their old neighborhood and care for the less fortunate, researchers report.The new findings, which also showed these doctors were more likely to.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Psilocybin could help people suffering from a mental health problem that can lead to eating disorders, a new study suggests.Psilocybin, the active chemical in “magic” mushrooms, significantly reduced symptoms in people wit.
Science Daily: Pharmacology News
SEPTEMBER 24, 2024
Speech consists of a continuous stream of acoustic signals, yet humans can segment words from each other with astonishing precision and speed. To find out how this is possible, a team of linguists has analysed durations of consonants at different positions in words and utterances across a diverse sample of languages. They have found that word-initial consonants are, on average, around 13 milliseconds longer than their non-initial counterparts.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Opioid use disorder can be a contributing factor to Americans landing in the nation's prisons and jails, but those inmates typically have no access to medications that could help wean them off the drugs.So finds a new.
PPD
SEPTEMBER 24, 2024
The enterprise of delivering life-changing medicines to patients involves a complex ecosystem, and in many ways, three key players reside at the core: drug sponsors, the contract research organizations (CROs) that support them and the clinical research sites directly engaging with patients in the trial. Many research sites’ overall sustainability relies heavily upon payments from sponsors and CROs.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Over 40 percent of U.S. adults are now obese, with rates roughly the same for men and women, new government data shows.Obesity rates fluctuated with age and fell as levels of education increased, said the report from the.
Science Daily: Pharmacology News
SEPTEMBER 24, 2024
Scientists conclude that some video games created as mental health interventions can be helpful -- if modest -- tools in improving the mental well-being of children and teens with anxiety, depression and attention-deficit/hyperactivity disorder (ADHD).
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Green Bay Packers legend and NFL Hall of Famer Brett Favre announced Tuesday that he has been diagnosed with Parkinson's disease.Favre, 54, made the announcement while testifying to Congress on his potential misuse of.
addgene Blog
SEPTEMBER 24, 2024
Lots of scientists work to invent novel techniques or to engineer improved tools for familiar applications. But how does one invent a tool for applications that don’t even exist yet? Andrew York , Maria Ingaramo, and their team at Calico Life Sciences recently set out to do just that — by developing a new fluorescent protein tool that responds strongly to magnetic fields ( Frank Hayward et al., 2024 ).
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Science Daily: Pharmacology News
SEPTEMBER 24, 2024
Northeast Greenland is home to the 79 N Glacier -- the country's largest floating glacier tongue, but also one seriously threatened by global warming: warm water from the Atlantic is melting it from below. Experts have however now determined that the temperature of the water flowing into the glacier cavern declined from 2018 to 2021, even though the ocean has steadily warmed in the region over the past several decades.
Covalent Modifiers
SEPTEMBER 24, 2024
Yuanjin Zhang, Zhonglin Liu, Marscha Hirschi, Oleg Brodsky, Eric Johnson, Sang Joon Won, Asako Nagata, Divya Bezwada, Matthew D. Petroski, Jaimeen D. Majmudar, Sherry Niessen, Todd VanArsdale, Adam M. Gilbert, Matthew M. Hayward, Al E. Stewart, Andrew R. Nager, Bruno Melillo & Benjamin F. Cravatt Nat Chem Biol , 2024 [link] More than half of the ~20,000 protein-encoding human genes have paralogs.
Science Daily: Pharmacology News
SEPTEMBER 24, 2024
Astronomers have observed the atmosphere of a hot and uniquely inflated exoplanet using NASA's James Webb Space Telescope.
BioPharma Drive: Drug Pricing
SEPTEMBER 24, 2024
Metsera revealed Phase 1 data it claims could support a weight-loss medicine that's administered monthly. Elsewhere, Sanofi invested in a struggling biotech and shares of two Duchenne drug developers climbed.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Patent Watch
SEPTEMBER 24, 2024
The development of generic drugs has become increasingly complex, requiring advanced analytical technologies to ensure the quality and efficacy of these products. Recent advancements in analytical technologies have significantly impacted the development of generic drugs, enabling more accurate and efficient analysis of complex drug products.
BioPharma Drive: Drug Pricing
SEPTEMBER 24, 2024
The announced job cuts are the latest in a series of steps Bluebird has taken to preserve cash and break even financially amid slow uptake of its marketed gene therapies.
Drug Target Review
SEPTEMBER 24, 2024
In the first article in this series, published on Wednesday 14 August, the significance of data quality for the effectiveness of data analyses by machine learning (ML) and AI was discussed. In this article, John Conway, Chief Visioneer Officer at 20/15 Visioneers 1 and industry leader, shares his perspectives on addressing data quality issues in the life sciences industry with Dr Raminderpal Singh.
FDA Law Blog: Biosimilars
SEPTEMBER 24, 2024
By Deborah L. Livornese — FDA issued a Federal Register notice on September 13, 2024, seeking feedback on the Integrated Review format that the Center for Drug Evaluation and Research (CDER) began using as part of its New Drugs Regulatory Program (NDRP) modernization effort several years ago. The NDRP focused on six strategic objectives one of which was the implementation of the Integrated Assessment which per CDER was designed to “critically, collaboratively, and consistently assess whether inf
BioPharma Drive: Drug Pricing
SEPTEMBER 24, 2024
In an interview with PharmaVoice, Alicia Zhou, the new head of the nonprofit Cancer Research Institute, expressed a desire to foster deeper partnerships between scientists and the pharmaceutical industry.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- If a woman is already in a "prediabetic" state in her teen or college years, her odds for a serious complication of pregnancy later in life rises, new research shows.Ignoring prediabetes in teenagers "may represent a.
Antidote
SEPTEMBER 24, 2024
Finding patients who may be interested in your trial is often a difficult part of the clinical trial patient recruitment process. Once you have an interested patient, creating a positive experience and a seamless patient journey are both critical components to ensure they take the next step in determining their eligibility for your trial.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Surrogate moms have a higher risk of pregnancy complications than other pregnant women, a new study finds.About 8% of surrogate mothers developed a severe complication like high blood pressure or serious bleeding during.
Drug Channels
SEPTEMBER 24, 2024
Autumn is here! Curl up with your favorite pumpkin-spiced blog and savor these acorns that we’ve squirrelled away for you: Johnson & Johnson Innovative Medicines gives a peek inside its $43 billion gross-to-net bubble Optum Rx joins the private label biosimilar bandwagon Biosimilars boom for provider-administered drugs Fresh evidence of how copay accumulators hurt patients Plus, words of wisdom from Cencora's soon-to-be-former CEO Steve Collis.
Drugs.com
SEPTEMBER 24, 2024
TUESDAY, Sept. 24, 2024 -- Pregnant women covered by Medicaid are less likely to get an ultrasound exam that can diagnose heart defects in a fetus, a new study finds.“The 20-week ultrasound is hugely important in detecting birth defects because it i.
ProRelix Research
SEPTEMBER 24, 2024
Biostatistics involves the application of statistical techniques for the design and analysis of clinical trial data. In addition to the conduct of trials which encompasses regulatory approval processes, informed consent, […] The post Understanding Biostatistical Services in Clinical Trials: A Comprehensive Breakdown appeared first on ProRelix Research.
Drug Channels
SEPTEMBER 24, 2024
Autumn is here! Curl up with your favorite pumpkin-spiced blog and savor these acorns that we’ve squirrelled away for you: Johnson & Johnson Innovative Medicines gives a peek inside its $43 billion gross-to-net bubble Optum Rx joins the private label biosimilar bandwagon Biosimilars boom for provider-administered drugs Fresh evidence of how copay accumulators hurt patients Plus, words of wisdom from Cencora's soon-to-be-former CEO Steve Collis.
Perficient: Drug Development
SEPTEMBER 24, 2024
Earlier this year, Adobe introduced new generative AI capabilities in A dobe E xperience M anager (AEM). As a Platinum partner of Adobe , Perficient has early adopter features provisioned for our environments. One of the more exciting and relevant features is the ability to use GenAI to generate variations within Content Fragments in AEM. In this blog, we’ll talk about a sample use-case scenario, the steps involved with this new feature, and show how it can empower marketers and content au
Fierce BioTech
SEPTEMBER 24, 2024
Unlocking European market access for rare disease therapies The European orphan drug market presents a significant opportunity for biotech firms. Learn more about early access programs (EAPs), and how they are emerging as a critical strategy for successfully launching rare disease therapies in this complex and diverse market. tharilall Tue, 09/24/2024 - 11:49 The European orphan drug market presents a significant opportunity for biotech firms.
Science Daily: Pharmacology News
SEPTEMBER 24, 2024
Climate scientists and permafrost experts show that, according to new climate computer model simulations, global warming will accelerate permafrost thawing and as a result lead to an abrupt intensification of wildfires in the Subarctic and Arctic regions of northern Canada and Siberia.
Expert insights. Personalized for you.
122 
Let's personalize your content